271 related articles for article (PubMed ID: 32457312)
21. LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer.
Dey G; Bharti R; Braley C; Alluri R; Esakov E; Crean-Tate K; McCrae K; Joehlin-Price A; Rose PG; Lathia J; Gong Z; Reizes O
J Ovarian Res; 2023 Jun; 16(1):122. PubMed ID: 37370140
[TBL] [Abstract][Full Text] [Related]
22. Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ΞΆ.
Song L; McNeil EM; Ritchie AM; Astell KR; Gourley C; Melton DW
BMC Cancer; 2017 Dec; 17(1):864. PubMed ID: 29254481
[TBL] [Abstract][Full Text] [Related]
23. RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.
Mason JM; Dusad K; Wright WD; Grubb J; Budke B; Heyer WD; Connell PP; Weichselbaum RR; Bishop DK
Nucleic Acids Res; 2015 Mar; 43(6):3180-96. PubMed ID: 25765654
[TBL] [Abstract][Full Text] [Related]
24. In vitro role of Rad54 in Rad51-ssDNA filament-dependent homology search and synaptic complexes formation.
Tavares EM; Wright WD; Heyer WD; Le Cam E; Dupaigne P
Nat Commun; 2019 Sep; 10(1):4058. PubMed ID: 31492866
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.
Zhong A; Zhang H; Xie S; Deng M; Zheng H; Wang Y; Chen M; Lu R; Guo L
Oncol Rep; 2018 Apr; 39(4):1747-1756. PubMed ID: 29393493
[TBL] [Abstract][Full Text] [Related]
26. Homologous recombination deficiency real-time clinical assays, ready or not?
Fuh K; Mullen M; Blachut B; Stover E; Konstantinopoulos P; Liu J; Matulonis U; Khabele D; Mosammaparast N; Vindigni A
Gynecol Oncol; 2020 Dec; 159(3):877-886. PubMed ID: 32967790
[TBL] [Abstract][Full Text] [Related]
27. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
28. BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites.
Patel DS; Misenko SM; Her J; Bunting SF
J Cell Biol; 2017 Nov; 216(11):3521-3534. PubMed ID: 28912125
[TBL] [Abstract][Full Text] [Related]
29. OTUB2 Promotes Homologous Recombination Repair Through Stimulating Rad51 Expression in Endometrial Cancer.
Wan Q; Chen Q; Cai D; Zhao Y; Wu X
Cell Transplant; 2020; 29():963689720931433. PubMed ID: 32830515
[TBL] [Abstract][Full Text] [Related]
30. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.
Gupta VG; Hirst J; Petersen S; Roby KF; Kusch M; Zhou H; Clive ML; Jewell A; Pathak HB; Godwin AK; Wilson AJ; Crispens MA; Cybulla E; Vindigni A; Fuh KC; Khabele D
Gynecol Oncol; 2021 Jul; 162(1):163-172. PubMed ID: 33867143
[TBL] [Abstract][Full Text] [Related]
31. Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.
Wilson AJ; Sarfo-Kantanka K; Barrack T; Steck A; Saskowski J; Crispens MA; Khabele D
Gynecol Oncol; 2016 Oct; 143(1):143-151. PubMed ID: 27444036
[TBL] [Abstract][Full Text] [Related]
32. Scaffolding protein SPIDR/KIAA0146 connects the Bloom syndrome helicase with homologous recombination repair.
Wan L; Han J; Liu T; Dong S; Xie F; Chen H; Huang J
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10646-51. PubMed ID: 23509288
[TBL] [Abstract][Full Text] [Related]
33. Rad54 Phosphorylation Promotes Homologous Recombination by Balancing Rad54 Mobility and DNA Binding.
Lengert N; Spies J; Drossel B
Biophys J; 2019 Apr; 116(8):1406-1419. PubMed ID: 30961891
[TBL] [Abstract][Full Text] [Related]
34. TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair.
Hariharasudhan G; Jeong SY; Kim MJ; Jung SM; Seo G; Moon JR; Lee S; Chang IY; Kee Y; You HJ; Lee JH
Nucleic Acids Res; 2022 Feb; 50(3):1501-1516. PubMed ID: 35061896
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Rad51 sensitizes breast cancer cells with wild-type PTEN to olaparib.
Zhao Q; Guan J; Zhang Z; Lv J; Wang Y; Liu L; Zhou Q; Mao W
Biomed Pharmacother; 2017 Oct; 94():165-168. PubMed ID: 28759753
[TBL] [Abstract][Full Text] [Related]
36. Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitors.
Lin ZP; Ratner ES; Whicker ME; Lee Y; Sartorelli AC
Mol Cancer Res; 2014 Mar; 12(3):381-393. PubMed ID: 24413181
[TBL] [Abstract][Full Text] [Related]
37. Functional connection between Rad51 and PML in homology-directed repair.
Boichuk S; Hu L; Makielski K; Pandolfi PP; Gjoerup OV
PLoS One; 2011; 6(10):e25814. PubMed ID: 21998700
[TBL] [Abstract][Full Text] [Related]
38. Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.
Guffanti F; Alvisi MF; Anastasia A; Ricci F; Chiappa M; Llop-Guevara A; Serra V; Fruscio R; Degasperi A; Nik-Zainal S; Bani MR; Lupia M; Giavazzi R; Rulli E; Damia G
Br J Cancer; 2022 Jan; 126(1):120-128. PubMed ID: 34732853
[TBL] [Abstract][Full Text] [Related]
39. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
Xiao M; Cai J; Cai L; Jia J; Xie L; Zhu Y; Huang B; Jin D; Wang Z
J Ovarian Res; 2017 Apr; 10(1):24. PubMed ID: 28376831
[TBL] [Abstract][Full Text] [Related]
40. ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
Liu L; Cai S; Han C; Banerjee A; Wu D; Cui T; Xie G; Zhang J; Zhang X; McLaughlin E; Yin M; Backes FJ; Chakravarti A; Zheng Y; Wang QE
Mol Cancer Ther; 2020 Jan; 19(1):199-210. PubMed ID: 31534014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
